Achievements in the field of innovation of new Chinese medicines
From September 7th to 9th, the 2024 Healthy China (Hengqin) International Traditional Chinese Medicine Health and Science and Technology Industry Expo was held grandly in the Hengqin Guangdong-Macao Deep Cooperation Zone, with the theme of “Inheritance, Propaganda, Openness, Integration – Science and Technology Innovation Empowering Integrated Development of Traditional Chinese Medicine.” Guizhou Bailing Group and its subsidiaries Beletalent and Macao G-RX brought its innovative products to the expo, and Group R&D Director Xia Wen was invited to attend and give a keynote speech, fully showcasing the company’s profound accumulation and innovative strength in the field of traditional Chinese medicine.
The expo invited representatives from the national traditional Chinese medicine system, leading traditional Chinese medicine enterprises, traditional Chinese medicine colleges and universities, industry associations, and investment and financing institutions to participate. A total of 126 enterprises, universities, and industry associations from all provinces and cities across the country, including Hong Kong and Macao, participated in the exhibition, and 485 units of various types participated in the conference. Among them, Guangdong, Guangxi, Guizhou, Shanxi, Gansu, Shenzhen and other provinces and cities formed delegations to participate.
At the expo site, Guizhou Bailing showcases large varieties of traditional Chinese medicine such as Yindan Xinnaotong softgel, Kexuting syrup, as well as Tangning Tongluo tablets, Huanglianjiedu pills,Yishenhuozhuo granules, BD77 atomizing agent, Shao Ling tablets, Bingliancao lozenges and other drugs with independent intellectual property rights and scientific research and innovation advantages, and through detailed interpretation, interactive communication and other ways. Attracted many representatives to stop to pay attention and negotiate.
At the Traditional Chinese Medicine Innovation Achievements Promotion Conference, Director Xia Wen delivered a keynote speech entitled “Guizhou Bailing Traditional Chinese Medicine Innovation Achievements”, sharing the exploration and practice of transforming Tangning Tongluo from medical institutions’ preparations into new drugs. This aroused strong interest among the delegates, who took the initiative to contact him, hoping to carry out scientific research cooperation, demonstrating Guizhou Bailing’s strength and style in the field of new Chinese medicine innovation.